Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage I
Interventions: DRUG: Capecitabine，Pyrotinib
Sponsor: Fudan University